The FDA issued a notice determining that the recall of ICU Medical (Nasdaq:ICUI) infusion pump batteries is Class I, the most serious kind. ICU Medical initiated a recall of replacement batteries for certain infusion systems on March 22, 2023. The recall affects its Plum 360, Plum A+ and Plum A+3 infusion systems. The infusion systems […]
ICU Medical
Report: ICU Medical, GE HealthCare to battle over Medtronic units
Reuters reported today that ICU Medical and GE HealthCare are pursuing two business units Medtronic aims to sell off. The outlet cites sources familiar with the situation, saying the companies are looking at Medtronic’s patient monitoring and respiratory interventions businesses. According to Reuters, Medtronic values these businesses between $8 billion and $9 billion. In October, Medtronic […]
ICU Medical stock slides on mixed Q4, projected 2023 losses
ICU Medical (Nasdaq:ICUI) shares took a hit today on fourth-quarter results that came in mixed compared to the consensus forecast. Shares of ICUI fell 6.2% at $166.70 apiece just after the market opened today. The San Clemente, California-based company posted losses of $15.5 million in the quarter. That amounts to 65¢ per share on sales […]
Smiths Medical issues urgent device correction for some CADD infusion pumps
Smiths Medical today issued an urgent medical device correction letter to inform customers of potential issues with its CADD infusion system. The company — which ICU Medical acquired in January for $2.35 billion — identified two potential issues with the infusion sets. They relate to the potential lack of delivery or underdelivery and false no […]
10 big earnings stories from the last quarter: How are medtech stocks doing now?
Economic uncertainty appears to have produced a wide variety of medtech earnings stories during the most recent round of quarterly results. Some medical device companies received massive boosts from their quarterly performance, while others saw their stocks sink amid missed projections and other various issues. The phrase “macroeconomic headwinds” was a common phrase. Medtech faces […]
ICU Medical stock sinks on Q2 misses, slashed 2022 guidance
ICU Medical (Nasdaq:ICUI) shares took a hit on second-quarter results that came up shy of the consensus forecast. Shares of ICUI were down 6.4% at $176 per share before the market opened today. They had closed yesterday up 4.7% at $188.10 per share. The San Clemente, California-based company posted losses of $7.5 million, or 31¢ […]
ICU Medical reports a Street-beating Q1
ICU Medical (Nasdaq:ICUI) reported first-quarter results that came in ahead of the consensus earnings per share forecast. The San Clemente, California-based company yesterday evening posted losses of $38.1 million, or $1.61 per share, on sales of $543.1 million for the three months ended March 31, 2022, for a bottom-line slide into the red on sales growth […]
These 10 medtech companies’ stocks performed best in 2021
Following a year like no other in 2020, 2021 was when many looked to rebound — including the medtech industry. A number of medtech companies followed up a challenging, pandemic-enveloped year with impressive performances. Plenty of them had already proven in 2020 that they were capable of a quick bounce-back. Here are 10 medtech companies […]
ICU Medical beats The Street in Q4, posts full-year guidance
ICU Medical (NASDAQ:ICUI) shares rose today on fourth-quarter results that came in ahead of the consensus forecast. The San Clemente, California–based infusion therapy, oncology, and critical care tech company posted profits of $19.9 million, or 91¢ per share, on sales of $340.5 million for the three months ended Dec. 31, 2021, for a 23.8% bottom-line […]
ICU Medical completes $2.35B purchase of Smiths Medical
ICU Medical (NASDAQ:ICUI) recently announced that it has completed its $2.35 billion acquisition of Smiths Medical from the Smiths Group. Smiths Medical’s business includes syringe and ambulatory infusion devices, vascular access, and vital care products. The merger creates an infusion therapy company with estimated annual revenues of roughly $2.5 billion, ICU Medical said in a […]
ICU Medical’s Smiths Medical acquisition remains on track
ICU Medical (NASDAQ:ICUI) is a step closer to acquiring Smiths Medical after clearing a shareholders vote at Smiths’ British parent company, the Smiths Group. Almost all of the nearly 327 million Smiths Group shareholders voting on November 17 approved the $2.35 billion buy. Get the full story on our sister site Medical Tubing + Extrusion.
